MT-2, Melanotan 2 Acetate
Pharmaceutical Grade
99%
shanghai
MT-2
vial box
2027-01-20
Peptides,steriods oil,pharmaceutical intermediates,chemical,raw powder,Retatrutide
-
Product Description
-
Seller Information
-
History Price
-
DescriptionBasic Info
-
Product Name:
Melanotan 2 Acetate ,lose weight
Categories:
Research-
Class:
Synthetic cyclic heptapeptide / non-selective melanocortin receptor agonist
Status:Research compound — NOT FDA approved. FDA issued warning letters. WADA banned substance.
Mechanism:A synthetic cyclic heptapeptide (Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH₂) analog of α-MSH. Melanotan II is a high-affinity non-selective agonist at MC1R, MC3R, MC4R, and MC5R. MC1R activation induces melanogenesis (skin darkening/tanning); MC4R activation affects sexual function, appetite suppression, and energy homeostasis. Carries significant safety risks including nausea, hypertension, and priapism.
EC50 (Human Mc1r Ki):1.2 nM
EC50 (Human Mc5r Ki):1.0 nM
EC50 (Human Mc3r Ki):1.1 nM
EC50 (Human Mc4r Ki):2.1 nM
Source:Wikberg JES, et al. Pharmacol Res. 2000;42(5):393–420. PubChem CID 92432.DOI
Clinical Development:
References-
ChEMBL:
CHEMBL363210
PubChem:Literature:FDA Warning Letters: Melanotan II (unapproved drug); WADA Prohibited List: Melanotan II (S2 hormone modulator)
Disclaimer:Melanotan II is NOT FDA-approved. The FDA has issued multiple warning letters to companies illegally selling Melanotan II as an unapproved new drug. It is also listed on the WADA Prohibited List as a banned substance in sport. This listing is for industrial and laboratory research use only. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Peptides,steriods oil,pharmaceutical intermediates,chemical,raw powder,Retatrutide
-
Location:
15b3-1, Building 3, China Plastic City International Business Center, No. 285 Shunda West Road, Yangming Street, Ningbo, Zhejiang, China
-
Payment Terms:
TT against copy of documents,TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
5
-
Total Annual Revenue:
$5 million-$10 million
-
Total Employees:
11-50
-
Year of Establishment:
2024
-
-
Weekly Price
The chart shows the price trend of the product in the past 12 months.
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product
- Hot Searches
- prednisolone vs prednisolone sodium phosphate
- bioglutide peptide for sale
- gymtessa
- alunina
- urea fertilizer price
- tirzepatide 60mg peptide
- amopeptide
- best place to buy research tirzepatide
- ammonium nitrate prills
- where to buy anhydrous ammonia
- disulfur hexafluoride
- chemical compound of acetone